1. Home
  2. PPCB

PPCB

Propanc Biopharma Inc.

as 11-26-2025 10:54am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Nasdaq

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Founded: 2007 Country:
Australia
Australia
Employees: N/A City: CAMBERWELL, VICTORIA
Market Cap: 20.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 225.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.00 EPS Growth: N/A
52 Week Low/High: $0.73 - $145.46 Next Earning Date: 11-17-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest Propanc Biopharma Inc. News

PPCB Breaking Stock News: Dive into PPCB Ticker-Specific Updates for Smart Investing

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results

GlobeNewswire

10 days ago

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results

All PPCB News

Compare PPCB vs Leading Stocks

PPCB VS RAY

PPCB VS BATL

PPCB VS ATHA

PPCB VS JVA

PPCB VS DARE

PPCB VS SPPL

PPCB VS SJ

PPCB VS LEXX

Share on Social Networks:

Free PPCB Stock Widget

Embed our stock ticker widget on your website.

Stock Traders Forum

Community for stock traders to ask questions, gain insights, and learn.

Stock Alerts on Telegram

Subscribe to our Telegram channel for stock tips & insights.

Similar to PPCB Stocks: